Joint Clinical Trials Office

You are here

PRESERVE-Zenith® Iliac Branch Clinical Study

Clinical Trial Details

The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Key Eligibility: 

Inclusion Criteria:

  1. An aortoiliac or iliac aneurysm of appropriate size
  2. Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the common iliac artery

Exclusion Criteria:

  1. Less than 18 years of age
  2. Inability or refusal to give informed consent
  3. Disease considerations that would compromise patient safety or study outcomes
  4. Unsuitable arterial anatomy

Study contact by location

Upper East Side - Manhattan

Contact(s)

Eniola Odukale
(646) 962-8444
eno4001@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1103011594

ClinicalTrials.gov:

NCT02475798

Sponsor:

G070241

Status

Open to Enrollment

Age Group

Adult

Sponsor